AA · Insider Trading
Alcoa Corporation
Every open-market purchase and sale reported by AA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Andrew Hastings | EVP & Gen. Counsel | MIXED | −1,087 | −$173.29K |
| 2026-09-01 | Renato Bacchi | EVP & Chief Commercial Officer | Sell | −700 | −$35.71K |
| 2026-08-28 | Tammi A Jones | EVP & CHRO | Sell | −15,628 | −$790.73K |
| 2026-08-18 | Andrew Hastings | EVP & Gen. Counsel | Sell | −6,000 | −$305.41K |
| 2026-07-23 | Matthew T Reed | EVP, Chief Operations Officer | Sell | −4,600 | −$215.37K |
| 2026-05-12 | John A Bevan | Director | A | +2,532 | — |
| 2026-05-12 | Mary Anne Citrino | Director | A | +2,532 | — |
| 2026-05-12 | Alistair Field | Director | A | +2,532 | — |
| 2026-05-12 | Pasquale Fiore | Director | A | +2,532 | — |
| 2026-05-12 | Brian Galovich | Director | A | +2,532 | — |
| 2026-05-12 | Thomas Joseph Gorman | Director | A | +2,532 | — |
| 2026-05-12 | James Alton Hughes | Director | A | +2,532 | — |
| 2026-05-12 | Marques Roberto de Oliveira | Director | A | +2,532 | — |
| 2026-05-12 | Carol L Roberts | Director | A | +2,532 | — |
| 2026-05-12 | Jackson Prince Roberts | Director | A | +2,532 | — |
| 2026-04-17 | Emily M. Olson | EVP & Chief Ext. Aff. Officer | A | +8,760 | — |
| 2026-02-25 | William F Oplinger | President, CEO & Director | MIXED | +4,939 | −$227.34K |
| 2026-02-25 | Molly S. Beerman | EVP & CFO | MIXED | +3,950 | −$181.82K |
| 2026-02-25 | Renato Bacchi | EVP & Chief Commercial Officer | MIXED | +2,745 | −$126.38K |
| 2026-02-25 | Tammi A Jones | EVP & CHRO | MIXED | +2,575 | −$165.79K |
| 2026-02-02 | William F Oplinger | President, CEO & Director | F | −14,840 | −$899.90K |
| 2026-02-02 | Molly S. Beerman | EVP & CFO | F | −3,940 | −$238.92K |
| 2026-02-02 | Renato Bacchi | EVP & Chief Commercial Officer | F | −2,290 | −$138.87K |
| 2026-02-02 | Andrew Hastings | EVP & Gen. Counsel | F | −1,736 | −$105.27K |
| 2026-02-02 | Renee Henry | SVP & Controller | F | −366 | −$22.19K |
| 2026-02-02 | Tammi A Jones | EVP & CHRO | MIXED | −3,483 | −$211.21K |
| 2026-01-30 | William F Oplinger | President, CEO & Director | A | +66,660 | — |
| 2026-01-30 | Molly S. Beerman | EVP & CFO | A | +17,340 | — |
| 2026-01-30 | Renato Bacchi | EVP & Chief Commercial Officer | A | +9,340 | — |
| 2026-01-30 | Andrew Hastings | EVP & Gen. Counsel | A | +11,210 | — |
| 2026-01-30 | Renee Henry | SVP & Controller | A | +1,770 | — |
| 2026-01-30 | Tammi A Jones | EVP & CHRO | A | +13,510 | — |
| 2026-01-30 | Matthew T Reed | EVP, Chief Operations Officer | A | +20,810 | — |
| 2026-01-28 | William F Oplinger | President, CEO & Director | F | −21,078 | −$1.23M |
| 2026-01-28 | Molly S. Beerman | EVP & CFO | F | −10,205 | −$597.50K |
| 2026-01-28 | Renato Bacchi | EVP & Chief Commercial Officer | F | −7,214 | −$422.38K |
| 2026-01-28 | Andrew Hastings | EVP & Gen. Counsel | F | −1,758 | −$102.93K |
| 2026-01-28 | Renee Henry | SVP & Controller | F | −1,303 | −$76.29K |
| 2026-01-28 | Tammi A Jones | EVP & CHRO | MIXED | −9,781 | −$572.68K |
| 2025-07-07 | Steven W Williams | Director | A | +1,022 | +$31.84K |
| 2025-05-14 | John A Bevan | Director | A | +5,690 | — |
| 2025-05-14 | Mary Anne Citrino | Director | A | +5,690 | — |
| 2025-05-14 | Alistair Field | Director | A | +5,690 | — |
| 2025-05-14 | Pasquale Fiore | Director | A | +5,690 | — |
| 2025-05-14 | Thomas Joseph Gorman | Director | A | +5,690 | — |
| 2025-05-14 | James Alton Hughes | Director | A | +5,690 | — |
| 2025-05-14 | Marques Roberto de Oliveira | Director | A | +5,690 | — |
| 2025-05-14 | Carol L Roberts | Director | A | +5,690 | — |
| 2025-05-14 | Jackson Prince Roberts | Director | A | +5,690 | — |
| 2025-05-14 | Ernesto Zedillo | Director | A | +5,690 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| William F Oplinger | President, CEO & Director | 338,221 | $14.02M |
| Molly S. Beerman | EVP & CFO | 122,501 | $5.08M |
| Steven W Williams | Director | 101,678 | $4.21M |
| Renato Bacchi | EVP & Chief Commercial Officer | 74,930 | $3.11M |
| Matthew T Reed | EVP, Chief Operations Officer | 71,770 | $2.97M |
| Mary Anne Citrino | Director | 56,665 | $2.35M |
| Ernesto Zedillo | Director | 54,771 | $2.27M |
| James Alton Hughes | Director | 53,630 | $2.22M |
| Carol L Roberts | Director | 53,630 | $2.22M |
| Tammi A Jones | EVP & CHRO | 51,784 | $2.15M |
| Pasquale Fiore | Director | 40,761 | $1.69M |
| Andrew Hastings | EVP & Gen. Counsel | 35,007 | $1.45M |
| Nicol Gagstetter | EVP & Chief Ext. Aff. Officer | 23,438 | $971.51K |
| Thomas Joseph Gorman | Director | 23,327 | $966.90K |
| John A Bevan | Director | 20,761 | $860.54K |
| Jackson Prince Roberts | Director | 19,672 | $815.40K |
| Marques Roberto de Oliveira | Director | 15,800 | $654.91K |
| Renee Henry | SVP & Controller | 12,981 | $538.06K |
| Alistair Field | Director | 12,199 | $505.65K |
| Emily M. Olson | EVP & Chief Ext. Aff. Officer | 8,760 | $363.10K |
| Brian Galovich | Director | 2,532 | $104.95K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.